Cargando…

Amyloid fibrils and prefibrillar aggregates : molecular and biological properties /

Summing up almost a decade of biomedical research, this topical handbook is a reference on the topic which incorporates recent breakthroughs in amyloid research. The first part covers the structural biology of amyloid fibrils and pre-fibrillar assemblies. The second part looks at the diagnosis and b...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Otzen, Daniel Erik, 1969-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Weinheim : Wiley-VCH, [2013]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn846495244
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 130603s2013 gw a ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d COO  |d E7B  |d OCLCF  |d RIV  |d YDXCP  |d DEBSZ  |d IDEBK  |d OCLCQ  |d COCUF  |d MOR  |d CCO  |d PIFAG  |d ZCU  |d MERUC  |d OCLCQ  |d U3W  |d STF  |d WRM  |d NRAMU  |d ICG  |d INT  |d VT2  |d OCLCO  |d AU@  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d OCLCQ  |d DKC  |d OCLCQ  |d UKAHL  |d UKCRE  |d VLY  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
066 |c (S 
015 |a GBB2A7777  |2 bnb 
016 7 |a 101609992  |2 DNLM 
016 7 |a 016196086  |2 Uk 
019 |a 847138826  |a 961562803  |a 962701968  |a 988518494  |a 992074664  |a 1037784630  |a 1038597756  |a 1045505928  |a 1055327254  |a 1058164084  |a 1065682720  |a 1081265131  |a 1153546824  |a 1162584229  |a 1228570841  |a 1290097727  |a 1303514013 
020 |a 9783527654215  |q (electronic bk.) 
020 |a 3527654216  |q (electronic bk.) 
020 |a 9781299633773  |q (MyiLibrary) 
020 |a 1299633773  |q (MyiLibrary) 
020 |z 9783527332007 
020 |z 3527332006 
020 |z 9783527654208  |q (ePub) 
020 |z 9783527654192  |q (mobi) 
020 |z 9783527654185  |q (oBook) 
020 |a 3527654208 
020 |a 9783527654208 
020 |a 3527654186 
020 |a 9783527654185 
029 1 |a AU@  |b 000053030544 
029 1 |a DEBBG  |b BV044175900 
029 1 |a DEBSZ  |b 431429618 
029 1 |a NZ1  |b 15348249 
029 1 |a AU@  |b 000062469679 
029 1 |a AU@  |b 000073077317 
035 |a (OCoLC)846495244  |z (OCoLC)847138826  |z (OCoLC)961562803  |z (OCoLC)962701968  |z (OCoLC)988518494  |z (OCoLC)992074664  |z (OCoLC)1037784630  |z (OCoLC)1038597756  |z (OCoLC)1045505928  |z (OCoLC)1055327254  |z (OCoLC)1058164084  |z (OCoLC)1065682720  |z (OCoLC)1081265131  |z (OCoLC)1153546824  |z (OCoLC)1162584229  |z (OCoLC)1228570841  |z (OCoLC)1290097727  |z (OCoLC)1303514013 
037 |a 494627  |b MIL 
050 4 |a QP552.A45  |b A49 2013eb 
060 4 |a 2013 E-919 
060 4 |a QU 55 
072 7 |a QP  |2 lcco 
072 7 |a SCI  |x 007000  |2 bisacsh 
082 0 4 |a 572.68  |2 23 
049 |a UAMI 
245 0 0 |a Amyloid fibrils and prefibrillar aggregates :  |b molecular and biological properties /  |c edited by Daniel Erik Otzen. 
260 |a Weinheim :  |b Wiley-VCH,  |c [2013] 
300 |a 1 online resource (xxviii, 481 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
520 8 |a Summing up almost a decade of biomedical research, this topical handbook is a reference on the topic which incorporates recent breakthroughs in amyloid research. The first part covers the structural biology of amyloid fibrils and pre-fibrillar assemblies. The second part looks at the diagnosis and biomedical study of amyloid in humans and in animal models, while the final section discusses pharmacological approaches to manipulating amyloid. 
588 0 |a Print version record. 
505 0 |a Amyloid Fibrils and Prefibrillar Aggregates -- Contents -- Preface -- List of Contributors -- 1 The Amyloid Phenomenon and Its Significance -- 1.1 Introduction -- 1.2 The Nature of the Amyloid State of Proteins -- 1.3 The Structure and Properties of Amyloid Species -- 1.4 The Kinetics and Mechanism of Amyloid Formation -- 1.5 The Link between Amyloid Formation and Disease -- 1.6 Strategies for Therapeutic Intervention -- 1.7 Looking to the Future -- 1.8 Summary -- Acknowledgments -- References -- 2 Amyloid Structures at the Atomic Level: Insights from Crystallography -- 2.1 Atomic Structures of Segments of Amyloid-Forming Proteins -- 2.1.1 Protein Segments That Form Amyloid-Related Crystals -- 2.1.2 Atomic Structures of Fiber-Like Microcrystals -- 2.2 Stability of Amyloid Fibers -- 2.3 Which Proteins Enter the Amyloid State? -- 2.4 Molecular Basis of Amyloid Polymorphism and Prion Strains -- 2.5 Atomic Structures of Steric Zippers Suggest Models for Amyloid Fibers of Parent Proteins -- 2.6 Atomic Structures of Steric Zippers Offer Approaches for Chemical Interventions against Amyloid Formation -- 2.7 Summary -- Acknowledgments -- References -- 3 What Does Solid-State NMR Tell Us about Amyloid Structures? -- 3.1 Introduction -- 3.2 Principles of Solid-State NMR Spectroscopy and Experiments for Structural Constraints -- 3.2.1 Isotope Labeling, Magic Angle Spinning, Dipolar Coupling, and Resonance Assignment -- 3.2.2 De.ning the Amyloid Core by Magnetization Transfer from Water -- 3.2.3 Determining the Fibril Registry -- 3.2.4 Seeded versus Unseeded Fibrils -- 3.3 Amyloid Fibrils Investigated by Solid-State NMR Spectroscopy -- 3.3.1 AÝ peptides of Different Length -- 3.3.2 Islet Amyloid Polypeptide (IAPP/Amylin): Parallel and Antiparallel Steric Zippers -- 3.3.3 Ü-Synuclein: Polymorphism with Flexible Terminal Regions. 
505 8 |a 3.3.4 PrP: Rearrangements to Maintain a Fibrillar Core Region -- 3.3.5 Yeast Prions with Glutamine/Asparagine-Rich Prion Domains: Sup35p, Ure2p, and Rnq1p -- 3.3.6 Functional Amyloid: the Yeast Prion HET-s -- 3.4 Summary -- References -- 4 From Molecular to Supramolecular Amyloid Structures: Contributions from Fiber Diffraction and Electron Microscopy -- 4.1 Introduction -- 4.2 History -- 4.2.1 The Historical Use of X-ray Fiber Diffraction -- 4.2.2 The Historical Use of Transmission Electron Microscopy -- 4.3 Methodology -- 4.3.1 X-Ray Fiber Diffraction -- 4.3.2 Transmission Electron Microscopy -- 4.4 Recent Advances in Amyloid Structure Determination -- 4.4.1 X-ray Fiber Diffraction -- 4.4.2 Transmission Electron Microscopy -- 4.5 Summary -- Acknowledgments -- References -- 5 Structures of Aggregating Species by Small-Angle X-Ray Scattering -- 5.1 Introduction -- 5.2 Theoretical and Experimental Aspects -- 5.3 Data Analysis and Modeling Methods -- 5.4 Studying Protein Aggregation and Fibrillation Using SAXS -- 5.4.1 Some General Considerations -- 5.4.2 SAXS Studies of Insulin, Glucagon, and Ü-Synuclein -- 5.4.3 SDS-Induced Aggregation of Ü-Synuclein -- 5.4.4 Multi-Component Fitting and Analysis of SAXS Data -- 5.5 General Strategies for Modeling SAXS Data from Protein Complexes -- 5.6 Summary and Final Remarks -- Acknowledgments -- References -- 6 Structural and Compositional Information about Pre-Amyloid Oligomers -- 6.1 General Introduction -- 6.2 Biophysical Techniques to Study Amyloid Oligomers -- 6.2.1 Fluorescence Spectroscopy -- 6.2.1.1 Ensemble Spectroscopy -- 6.2.1.2 Single-Molecule Spectroscopy -- 6.2.2 Atomic Force Microscopy -- 6.2.3 Absorbance and Circular Dichroism Spectroscopy -- 6.2.4 Small-Angle X-Ray Scattering -- 6.2.5 Mass Spectrometry -- 6.3 The Structure and Composition of Amyloid Oligomers -- 6.3.1 Ü-Synuclein Oligomers. 
505 8 |a 6.3.1.1 Morphology -- 6.3.1.2 Oligomer Structure -- 6.3.1.3 Oligomer Composition -- 6.3.2 AÝ Peptide Oligomers -- 6.3.2.1 Morphology -- 6.3.2.2 Composition -- 6.4 Concluding Remarks -- Acknowledgments -- References -- 7 The Oligomer Species: Mechanistics and Biochemistry -- 7.1 Introduction -- 7.2 The Structure-Toxicity Relation of Early Amyloids -- 7.2.1 Antibodies Define Different Structural Classes of Oligomers and Fibrils -- 7.2.2 Proteins May Form Different Kinds of Oligomers with Different Structural and Biological Activities -- 7.3 The Oligomer-Membrane Complex -- 7.3.1 The Effect of Surfaces on Protein Misfolding and Aggregation -- 7.3.2 The Membrane Composition Affects Binding and Aggregation Processes -- 7.3.3 Complex Roles of Cholesterol and Gangliosides in Oligomer Cytotoxicity -- 7.4 Biochemical Modifications Underlying Amyloid Toxicity -- 7.4.1 A New View of the Amyloid Cascade Hypothesis -- 7.4.2 Amyloid Pores: a Mechanism for Cytotoxicity? -- 7.4.3 Other Mechanisms for Oligomer Cytotoxicity -- 7.4.3.1 Oxidative Stress and Amyloid Aggregates -- 7.4.3.2 Lipid Modification and Ca2+ Entry -- 7.4.3.3 The Complexity of Amyloid and Oligomer Polymorphism -- 7.5 Summary -- References -- 8 Pathways of Amyloid Formation -- 8.1 Introduction -- 8.2 Nomenclature of the Various Conformational States -- 8.3 Graphical Representations of the Mechanisms Leading to Amyloid -- 8.3.1 Time Course of Amyloid Content -- 8.3.2 Energy Landscapes of Amyloid Fibril Formation -- 8.3.3 Reaction Equilibria Involved in Amyloid Fibril Formation -- 8.4 Pathways of Amyloid Fibril Formation -- 8.5 Nucleation Growth versus Nucleated Conformational Conversion -- 8.6 Summary -- References -- 9 Sequence-Based Prediction of Protein Behavior -- 9.1 Introduction -- 9.2 The Strategy of the Zyggregator Predictions. 
505 8 |a 9.2.1 Prediction of the Effects of Amino Acid Substitutions on Protein Aggregation Rates -- 9.2.2 Prediction of the Overall Aggregation Rates of Peptides and Proteins -- 9.2.3 Prediction of Aggregation-Prone Regions in Amino Acid Sequences -- 9.3 Aggregation Under Other Conditions -- 9.3.1 Prediction of Protein Aggregation-Prone Regions in the Presence of Denaturants -- 9.3.2 Prediction of Aggregation-Prone Regions in Native States of Proteins -- 9.4 Prediction of the Cellular Toxicity of Protein Aggregates -- 9.5 Relationship to Other Methods of Predicting Protein Aggregation Propensities -- 9.6 Competition between Folding and Aggregation of Proteins -- 9.7 Prediction of Protein Solubility from the Competition between Folding and Aggregation -- 9.7.1 Sequence-Based Prediction of Protein Solubility -- 9.7.2 Prediction of the Solubility of Proteins Based on Their Cellular Abundance -- 9.8 Sequence-Based Prediction of Protein Interactions with Molecular Chaperones -- 9.9 Summary -- References -- 10 The Kinetics and Mechanisms of Amyloid Formation -- 10.1 Introduction -- 10.2 Classical Theory of Nucleated Polymerization -- 10.2.1 From Microscopic Processes to a Master Equation -- 10.2.2 Kinetic Equations for Experimental Observables -- 10.2.3 Characteristics of Oosawa-Type Growth -- 10.2.3.1 Nucleation and Growth Occur Simultaneously -- 10.2.3.2 The Early Stages of the Reaction Time Course Are Described by Polynomial Growth -- 10.2.3.3 The Late Stages of the Reaction Time Course are Described by Simple First-Order Kinetics -- 10.2.3.4 The Integrated Rate Laws Exhibit Scaling Behavior -- 10.2.4 Global Analysis of Experimental Data Using the Oosawa Theory -- 10.3 The Theory of Filamentous Growth with Secondary Pathways -- 10.3.1 Extending the Oosawa Framework to Include Fragmentation and Secondary Nucleation -- 10.3.2 Early Time Perturbative Solutions. 
505 8 |a 10.3.3 Characteristics of Exponential-Type Growth -- 10.3.3.1 The Early Stages of the Reaction Time Course Are Exponential -- 10.3.3.2 The Solution Exhibits Scaling Behavior -- 10.3.4 Global Analysis of Experimental Data Using Linearized Solutions -- 10.4 Self-Consistent Solutions for the Complete Reaction Time Course -- 10.4.1 The Key Phenomenological Parameters Depend on Combinations of the Microscopic Rate Constants -- 10.4.2 Reaction Time Course with Depleted Monomer Concentration -- 10.4.3 Global Analysis of Amyloid Reaction Kinetics Using Self-Consistent Solutions -- 10.5 Summary -- References -- 11 Fluorescence Spectroscopy as a Tool to Characterize Amyloid Oligomers and Fibrils -- 11.1 Introduction -- 11.2 Fluorescence Spectroscopy for Studies of Amyloid Reactions In vitro -- 11.2.1 Fluorescence Output Formats -- 11.2.2 Fluorescence Anisotropy -- 11.2.3 Single Molecule Detection -- 11.2.4 Conformational Probes -- 11.3 Cysteine-Reactive Fluorescent Probes -- 11.3.1 Environmentally Sensitive Probes -- Spectrochromic Stokes Shift Assay -- 11.3.2 Fluorescence Anisotropy Probes for Amyloid Oligomerization -- 11.3.3 Pyrene Excimer Formation Probes for amyloid Oligomer and Fibril Topology -- 11.3.4 Bifunctional Cysteine Reagents as Probes for Amyloid Oligomers and Fibrils -- 11.4 Amyloidotropic Probes for Amyloid Fibrils and Oligomeric States -- 11.4.1 Are There Selective Probes for Prefibrillar Oligomeric States? -- 11.4.2 Fluorescence Anisotropy of Small Molecule Probes for Capturing the Intermediate Oligomeric State -- 11.4.3 In vivo Fluorescent Probes for Amyloid Fibrils -- 11.5 Luminescent Conjugated Poly and Oligothiophenes LCPs and LCOs -- 11.5.1 Optical Properties of Chemically Defined LCOs -- 11.5.2 Bridging the Imaging and Spectroscopy Gap -- Microspectroscopy of In vivo Formed Amyloids. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Amyloid. 
650 1 2 |a Amyloid  |x chemistry 
650 1 2 |a Amyloid  |x pharmacokinetics 
650 2 |a Amyloid 
650 6 |a Amyloïde. 
650 7 |a SCIENCE  |x Life Sciences  |x Biochemistry.  |2 bisacsh 
650 7 |a Amyloid  |2 fast 
650 7 |a Bioquímica.  |2 lemac 
655 4 |a Llibres electrònics. 
700 1 |a Otzen, Daniel Erik,  |d 1969-  |1 https://id.oclc.org/worldcat/entity/E39PCjvmw9rmgGQ39FcbPVmq8K 
758 |i has work:  |a Amyloid fibrils and prefibrillar aggregates (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFKWW3htJKGCpbgRFWCKHP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Amyloid fibrils and prefibrillar aggregates.  |d Weinheim : Wiley-VCH, [2013]  |z 9783527332007  |w (OCoLC)829054952 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1205604  |z Texto completo 
880 8 |6 505-00/(S  |a 3 What Does Solid-State NMR Tell Us about Amyloid Structures3.1 Introduction; 3.2 Principles of Solid-State NMR Spectroscopy and Experiments for Structural Constraints; 3.2.1 Isotope Labeling, Magic Angle Spinning, Dipolar Coupling, and Resonance Assignment; 3.2.2 De.ning the Amyloid Core by Magnetization Transfer from Water; 3.2.3 Determining the Fibril Registry; 3.2.4 Seeded versus Unseeded Fibrils; 3.3 Amyloid Fibrils Investigated by Solid-State NMR Spectroscopy; 3.3.1 Aβ peptides of Different Length; 3.3.2 Islet Amyloid Polypeptide (IAPP/Amylin): Parallel and Antiparallel Steric Zippers. 
880 8 |6 505-00/(S  |a 3.3.3 α-Synuclein: Polymorphism with Flexible Terminal Regions3.3.4 PrP: Rearrangements to Maintain a Fibrillar Core Region; 3.3.5 Yeast Prions with Glutamine/Asparagine-Rich Prion Domains: Sup35p, Ure2p, and Rnq1p; 3.3.6 Functional Amyloid: the Yeast Prion HET-s; 3.4 Summary; References; 4 From Molecular to Supramolecular Amyloid Structures: Contributions from Fiber Diffraction and Electron Microscopy; 4.1 Introduction; 4.2 History; 4.2.1 The Historical Use of X-ray Fiber Diffraction; 4.2.2 The Historical Use of Transmission Electron Microscopy; 4.3 Methodology; 4.3.1 X-Ray Fiber Diffraction. 
880 8 |6 505-00/(S  |a 4.3.2 Transmission Electron Microscopy4.4 Recent Advances in Amyloid Structure Determination; 4.4.1 X-ray Fiber Diffraction; 4.4.2 Transmission Electron Microscopy; 4.5 Summary; Acknowledgments; References; 5 Structures of Aggregating Species by Small-Angle X-Ray Scattering; 5.1 Introduction; 5.2 Theoretical and Experimental Aspects; 5.3 Data Analysis and Modeling Methods; 5.4 Studying Protein Aggregation and Fibrillation Using SAXS; 5.4.1 Some General Considerations; 5.4.2SAXS Studies of Insulin, Glucagon, and α-Synuclein; 5.4.3SDS-Induced Aggregation of α-Synuclein. 
938 |a Askews and Holts Library Services  |b ASKH  |n AH26418077 
938 |a ebrary  |b EBRY  |n ebr10716610 
938 |a EBSCOhost  |b EBSC  |n 588000 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis25591180 
938 |a YBP Library Services  |b YANK  |n 9985335 
938 |a YBP Library Services  |b YANK  |n 10746539 
938 |a YBP Library Services  |b YANK  |n 12679471 
994 |a 92  |b IZTAP